Purpose-To evaluate optical coherence tomography (OCT) reproducibility in patients with diabetic macular edema (DME).
Introduction
Optical coherence tomography (OCT) is commonly used to measure macular thickness quantitatively, especially in conditions associated with macular vascular leakage such as diabetic macular edema (DME). With the increasing importance of OCT in patient care and the common use of OCT as a key outcome measure in clinical trials of DME, it is important to determine the reproducibility of OCT measures in a large population of patients with diabetes. Several previous studies report good reproducibility with a Humphrey 2000 OCT prototype system (Humphrey Instruments, Inc, Dublin, Calif), the first commercially available Zeiss 2000 OCT system (Carl Zeiss Meditec Inc., Dublin, Calif) and the current generation Zeiss Stratus OCT. 1-3 These studies report relative reproducibility of 4-6% and repeatability coefficients of 5-37 microns. 1-3 However, these studies involve relatively small numbers of patients (10-19) and eyes (10-22) and are not all specific to patients with DME. 1-3
In the current study, we report the intra-observer reproducibility of retinal thickness measurements made with the Zeiss OCT3 in 107 patients with DME. The images were obtained as part of a multi-center study conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) that assessed the diurnal variation of retinal thickness in eyes with DME.
Methods
The protocol and informed consent forms were approved by individual sites' institutional review boards. Each subject gave written informed consent for participation in the study. The protocol for the study of the diurnal changes in retinal thickness is described in a separate manuscript (submitted for publication) and is available on the DRCR.net website (www.drcr.net, date accessed October 1, 2006). Participants in the study had at least one eye with edema in the center of the macula by clinical exam and an OCT central subfield thickness of at least 225 microns. OCT scans were obtained from both eyes of these subjects at six time points between 8 a.m. and 4 p.m. by a certified operator using the OCT3 system (Carl Zeiss Meditec Inc., Dublin, California). Immediately following each imaging, a second scan was obtained by the same or a different operator. Scans of suboptimal quality (e.g., standard deviation > 10% of center point or signal strength score < 6) were repeated to obtain an adequate quality scan if possible.
The fast macular thickness map protocol was used for the OCT studies. All 6 mm radial scans consisted of 128 sampled locations along the radial line scan. The 6.0 mm display was used for this study. Three concentric circles with radii of 0.5 mm, 1.5 mm, and 3.0 mm defined the central, inner and outer subfields.
OCT images were obtained by 35 operators at 25 clinical sites from 212 eyes of 107 subjects. Of the 1,284 possible paired OCT scans (107 subjects × 2 eyes/subject × 6 time points/eye), there were 1,223 (95%) pairs available for analysis. Data were missing for 2 eyes that were not scanned at any time point (N=12) and for sporadic time points when either no scan or only one scan was obtained (N=49). For 1,028 (84%) of the 1,223 pairs, both replicate scans at a single time point were obtained by the same technician while a different technician obtained each of the two replicate scans for 195 (16%).
OCT scans were evaluated at the DRCR.net Reading Center at the University of WisconsinMadison. For 939 (77%) of the 1,223 OCT pairs, automated center point thickness measurements were deemed accurate for both scans. Center point thickness was measured manually using calipers from the retinal thickness map scans for one scan of 202 (17%) pairs and for both scans of 63 (5%) pairs for scans with a standard deviation of the center point thickness ≥ 10.5%, inaccurately drawn automated boundary lines, or decentration.
Nineteen (2%) pairs of scans were ungradable due to poor scan quality. Retinal morphology was assessed from OCT images for cystoid abnormalities (five-level grading scale), central subretinal fluid (three-level grading scale) and vitreoretinal interface abnormalities (three-level grading scale).
Statistical Methods
Reproducibility was assessed for three automated OCT measures: central subfield thickness, center point thickness, and retinal volume. Retinal volume represents a weighted average of the central, inner and outer subfields multiplied by the area of the grid, expressed in mm 3 ( Figure 2 ). For scans requiring manual grading, central subfield thickness was imputed from the manually-determined center point thickness using a regression equation since the correlation of the two measurements was 0.99 4 but retinal volume values were missing.
Both the absolute value of the difference between two measurements (expressed in microns) and the relative absolute difference (a percentage calculated by dividing the absolute value of the difference by the mean of the two measurements and multiplying by 100) were computed.
Reproducibility of OCT measures was assessed by calculating the Bland-Altman 5 coefficient of repeatability ( 2 ∑ (OCT1 − OCT2) 2 / n). This can be interpreted as the margin of error on a 95% confidence interval (CI) for the true change in thickness in an eye measured by OCT at two different time points (e.g., pre-and post-treatment). This value divided by the square root of 2 represents the margin of error on a 95% CI for the true thickness based on a single OCT measurement. The bootstrap resampling method was used to calculate a confidence interval for the margin of error and to handle correlated data from repeated measures on the same subject.
The relationship between reproducibility of OCT measures (absolute value of the paired differences was the outcome variable) and retinal morphology was assessed using repeated measures least squares regression models adjusted for retinal thickness, and accounting for the correlated data from both eyes and multiple times for each subject. Outliers were truncated at 3 standard deviations from the mean. Since most (84%) of the replicate OCTs were obtained by the same technician who obtained the initial OCT, the number of instances of a different technician obtaining both the initial and replicate OCT was too small to assess inter-observer reproducibility adequately as a primary analysis. However, since the results obtained by different technicians appeared similar to the results from the same technician, the data were pooled for the analyses.
Results
The 107 subjects had an average age of 59 ± 10 years; 49 (46%) were women, 73 (68%) were Caucasian, 16 (15%) African-American, 16 (15%) Hispanic, and 2 (2%) other races. Type 1 diabetes was present in 16 (15%) and type 2 in 91 (85%). Average duration of diabetes was 17 ± 9 years and mean HbA1c was 7.7 ± 1.6%. Eighteen (8%) of the 212 eyes had average central subfield thickness < 200 microns on the first replicate measurements of the day, 42 (20%) thickness of 200 -< 250 microns, 92 (43%) thickness of 250 -< 400 microns, and 60 (28%) thickness ≥ 400 microns. Table 1 shows the distribution of the differences between the first and second scans for central subfield thickness, center point thickness, and retinal volume. Central subfield measurements were more reproducible than center point measurements (half-width for the 95% CI for change = 38 microns versus 50 microns and 11% versus 17%, respectively, P<0.001).
The median absolute difference between replicate measurements of the central subfield was 7 microns (2%). As seen in Table 2 and Figure 1 , the reproducibility in microns of central subfield thickness was worse when the central subfield was thicker (P<0.001). A similar trend, though less pronounced, was observed for the relative absolute difference (P=0.04, Table 2 ).
We evaluated whether specific ocular findings affected OCT reproducibility (Table 3) . After accounting for retinal thickness, reproducibility did not appear to be affected by the presence of cystoid abnormalities, subretinal fluid, vitreomacular traction, or reduced visual acuity. Reproducibility was better when both scans had a standard deviation of the center point < 10.0% (half-width of the 95% CI for change 33 microns versus 56 microns, P<0.001). Results did not vary significantly among the participating sites (P=0.60).
Discussion
This study provides detailed information on the reproducibility of OCT measurements of retinal thickness in the setting of DME. The information is important to the clinician in assessing whether there has been a true change in retinal thickness between visits. The data are also valuable for clinical trial design and evaluation in terms of defining OCT outcome measures and in estimating sample size and power for comparing change in OCT measures between treatment groups.
Although measurement of central retinal thickness has been most commonly used in studies of DME, the automated measurement of retinal volume provided by the OCT machine may be useful particularly in studies of DME not requiring center involvement.
Measurements of the thickness of the center point have greater variability than measurements of the central subfield. This might be expected since center point values are critically dependent on centration of the scan and can vary substantially if evaluating a retinal area only a few microns away. In contrast, the central area distributes any change in location over a broader area and would be less sensitive to subtle changes in centration. In addition, center point thickness is an average of 6 values whereas central subfield thickness averages 512 values. When the automated thickness measurement of the center point provided by the OCT machine is incorrect, the center point thickness can usually be manually measured. With knowledge of the center point thickness, a value for the central subfield can be imputed since the correlation between the center point and central subfield approaches 1.0. Thus, since variability is less with the central subfield and missing data can be accounted for, in most cases the central subfield (rather than center point) is likely a better measure for following changes in centerinvolved DME in clinical studies and in clinical practice.
The results also indicate that reproducibility of central subfield measurements varies according to retinal thickness when expressed in microns, but not to a meaningful degree when expressed as a percentage. Thus, when deciding if a particular change in retinal thickness is real for an individual eye, it may be preferable to consider the percent change rather than the change in microns. For a randomized trial, change in microns controlling for the baseline thickness might be preferred since the degree of baseline thickness is likely to be balanced between groups in studies with sufficient patient numbers.
As might be expected, when both scans had a standard deviation of the center point <10.0%, paired scans had substantially less variability than pairs in which at least one scan had a standard deviation of the center point ≥ 10.0%. Other than standard deviation of the center point and the degree of retinal thickness, we did not identify any factors that influenced the reproducibility of the OCT macular thickness measurement including cystoid abnormalities, subretinal fluid, vitreomacular traction, and reduced visual acuity.
The results of our study are comparable with prior reports of diabetic patients which reported a reproducibility of 5 to 6%, repeatability coefficients of 21 to 37 microns for macular zones, and 0.29 for total macular volume. 1-3
In summary, replicate measurements of central subfield differ by approximately 2% in patients with DME. This is reasonably consistent throughout the range of retinal thickness. The results indicate that a change in central subfield thickness exceeding 11% is likely to be real, though this does not necessarily mean that such a small change is clinically meaningful. Retinal thickness reproducibility in microns varies according to the degree of thickness. A change of 23 microns is likely real when the subfield thickness is < 250 microns but a change of 33 and 56 microns or more is needed when the thickness is 250 -< 400 microns or ≥ 400 microns, respectively. Since percent change does not vary substantially with changes in macular thickness, it may represent a more clinically useful comparison value. Scans that have a high standard deviation of the center point have less reproducibility and should be viewed with caution when assessing the validity of an observed change in retinal thickness in patients with DME.
Figure 1. Relative Error versus Mean Central 1 Subfield Thickness
Plot of the relative difference between the second and first measurements of the central subfield by the mean central subfield thickness. Points above the horizontal reflect a larger second measurement than first. The horizontal lines represent a percent difference between the two measurements of 10%; for points outside these lines, the two measurements differed by more than 10%. Illustration of the output from an OCT3 scan, version 4 software. Table 3 Effect of Factors on Reproducibility of Central Subfield Thickness P-value obtained using least squares regression models accounting for the correlated data from both eyes and multiple times for each subject ‡ 8 nongradable pairs § 9 nongradable pairs
